Affinage

TCF7

Transcription factor 7 · UniProt P36402

Length
384 aa
Mass
41.6 kDa
Annotated
2026-06-10
100 papers in source corpus 45 papers cited in narrative 45 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 8/8 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

TCF-1 (encoded by TCF7) is a T lineage-specific HMG-box transcription factor that establishes and maintains the epigenetic and transcriptional identity of T and innate lymphoid cells (PMID:1989880, PMID:29466756). It recognizes a conserved A/T A/T CAAA/GAG heptamer motif in the enhancers of T cell-specific genes (CD3-epsilon, TCR-alpha/beta/delta) through minor-groove contacts mediated by its single HMG box, while a separate, context-dependent activation domain confers T cell-preferential transactivation (PMID:1827138, PMID:1836958, PMID:1639073, PMID:8253387). Acting as a pioneer factor, TCF-1 targets silent chromatin, displaces nucleosomes, and generates de novo accessibility even at repressively marked regions, and it organizes the 3D genome by co-occupying sites with CTCF and recruiting the cohesin loader NIPBL to drive long-range enhancer interactions and H3K27ac deposition (PMID:29466756, PMID:30420627, PMID:35726060). Through these activities TCF-1 specifies T lineage fate downstream of Notch by inducing Gata3, Bcl11b, and TCR genes, and marks the earliest ILC-committed progenitors (PMID:21814277, PMID:26280998, PMID:31358996). As a Wnt pathway effector, TCF-1 partners with beta-catenin/gamma-catenin via its N-terminal catenin-binding domain to sustain thymocyte survival (via Bcl-xL) and to program CD8 central memory differentiation (PMID:10221643, PMID:11477404, PMID:20457902). TCF-1 also operates as a context-dependent repressor: it directly silences LEF-1 to act as a tumor suppressor preventing T-ALL-like malignancy, maintains repressive chromatin at the IL-17 locus, and suppresses cytolytic/Tc17 programs through MAF and RORgt (PMID:23103132, PMID:21935461, PMID:31142588, PMID:33128876). It functions as a transcriptional hub for helper and follicular fate by activating Th-POK and Bcl6 while repressing Blimp1, and cooperates with partners including Runx3 (to silence Cd4), HEB, and LEF-1 (PMID:24836425, PMID:26214740, PMID:26214741, PMID:30420627). In CD8 T cells responding to chronic antigen, TCF-1 maintains the stem-like, PD-1+ progenitor exhausted population that underlies anti-tumor immunity and responses to checkpoint blockade, a function it also exerts in human T cells (PMID:31606264, PMID:33128876, PMID:33351785).

Mechanistic history

Synthesis pass · year-by-year structured walk · 17 steps
  1. 1991 High

    Established TCF-1 as a T cell-specific sequence-specific DNA-binding transcription factor, defining its molecular identity and the enhancers it controls.

    Evidence Protein purification, gel retardation, cotransfection/reporter assays and cDNA cloning across CD3-epsilon and TCR enhancers in human and mouse

    PMID:1827138 PMID:1836958 PMID:1989880

    Open questions at the time
    • Did not establish coactivator requirements
    • In vivo function untested at this stage
  2. 1992 High

    Defined the mechanism of DNA recognition, showing the HMG box binds the heptamer through minor-groove contacts.

    Evidence Methylation and DEPC interference footprinting plus base-substitution analysis comparing TCF-1 and SRY HMG boxes

    PMID:1639073

    Open questions at the time
    • No co-crystal structure of TCF-1-DNA complex
    • Did not address how binding translates to activation versus repression
  3. 1993 High

    Separated DNA binding from transactivation, identifying a context-dependent, T cell-preferential activation domain that requires cooperative enhancer occupancy.

    Evidence GAL4 fusion transactivation with deletion/substitution mutants in T cell lines

    PMID:8253387

    Open questions at the time
    • Identity of the cooperating factor at the time unresolved
    • Activation domain interaction partners not biochemically defined
  4. 1996 High

    Showed dual-promoter architecture and alternative splicing generate functionally distinct isoforms, some resembling LEF-1 and some lacking transactivation capacity.

    Evidence cDNA cloning, 5' RACE, Western blot and reporter assays

    PMID:7579399 PMID:8622675

    Open questions at the time
    • Isoform-specific in vivo functions not delineated
    • Regulation of isoform choice not resolved
  5. 1999 Medium

    Placed TCF-1 as the Wnt effector in T cells through beta-catenin interaction, revealing a cell-type-specific mode of Wnt pathway activation distinct from fibroblasts.

    Evidence TCF reporter assays with dominant-negative GSK-3beta and lithium across cell types

    PMID:10221643

    Open questions at the time
    • Reporter-based, did not test endogenous target genes
    • Mechanism of GSK-3beta independence unexplained
  6. 2001 High

    Demonstrated the catenin-binding domain is genetically required for thymocyte survival, placing TCF-1/beta-catenin upstream of anti-apoptotic Bcl-xL.

    Evidence Catenin-binding domain mutant knock-in, Bcl-2 transgene rescue, reporter mice and Wnt blockade

    PMID:11265645 PMID:11477404 PMID:15890681

    Open questions at the time
    • Direct binding of TCF-1 to Bcl-xL regulatory regions not shown
    • Relative contributions of beta- vs gamma-catenin partially resolved
  7. 2010 High

    Defined TCF-1 as essential for CD8 central memory differentiation, extending its Wnt-dependent role from thymus to peripheral memory programming.

    Evidence Tcf-1 knockout with LCMV infection, adoptive transfer, catenin-binding domain mutants

    PMID:20457902

    Open questions at the time
    • Direct memory-gene targets not fully mapped at this stage
    • Chromatin mechanism not yet addressed
  8. 2011 High

    Established TCF-1 as a T-lineage specification factor acting downstream of Notch and as an epigenetic repressor of the IL-17 locus.

    Evidence Forced expression in Notch1-deficient progenitors and ChIP for histone marks at IL-17 in knockout mice

    PMID:21814277 PMID:21935461

    Open questions at the time
    • Mechanism of de novo chromatin opening not yet demonstrated
    • Direct versus indirect target relationships incompletely resolved
  9. 2012 High

    Identified TCF-1 as a direct repressor of LEF-1 and a tumor suppressor whose loss drives T-ALL-like malignancy.

    Evidence Tcf7 knockout, conditional Lef1 rescue, ChIP and histopathology

    PMID:23103132

    Open questions at the time
    • Molecular basis of activation-versus-repression switch unresolved
    • Human leukemia relevance addressed only by analogy
  10. 2014 High

    Resolved how TCF-1 specifies helper versus cytotoxic identity, through Th-POK activation and physical cooperation with Runx3 to silence Cd4.

    Evidence Conditional knockout, Co-IP of TCF-1/Runx3 and ChIP

    PMID:24836425

    Open questions at the time
    • Stoichiometry/structure of TCF-1-Runx3 complex unknown
    • Reciprocal validation of interaction limited
  11. 2015 High

    Defined TCF-1 (with LEF-1) as a TFH-commitment hub binding Bcl6 and Prdm1 regulatory regions, and as required for ILC progenitor generation.

    Evidence ChIP of Bcl6/Prdm1, single and double Tcf7/Lef1 conditional knockouts, reporter mice and lineage tracing

    PMID:26214740 PMID:26214741 PMID:26280998

    Open questions at the time
    • Direct cofactors at Bcl6/Prdm1 not fully defined
    • Redundancy mechanisms with LEF-1 partially resolved
  12. 2018 High

    Demonstrated pioneer-factor activity and nucleosome displacement, showing TCF-1 opens silent chromatin and cooperates with HEB by protecting it from Notch-mediated degradation.

    Evidence ATAC-seq across developmental stages, ectopic expression in fibroblasts, ChIP-seq and Co-IP

    PMID:29466756 PMID:30420627

    Open questions at the time
    • Structural basis of nucleosome engagement undefined
    • Which domains mediate pioneering not dissected
  13. 2019 High

    Positioned TCF-1 at the bifurcation between terminal effectors and stem-like exhausted CD8 precursors during chronic infection, and as a brake on Tc17 differentiation.

    Evidence scRNA-seq, lineage tracing, conditional knockout in LCMV chronic infection and ATAC-seq

    PMID:31142588 PMID:31358996 PMID:31606264

    Open questions at the time
    • Direct targets driving the precursor program incompletely mapped
    • Upstream signals stabilizing TCF-1+ cells not yet defined here
  14. 2020 High

    Showed TCF-1 sustains stemness and counters cytolytic differentiation in CD8 cells, while its own downregulation in exhaustion is enforced by Tcf7 promoter DNA methylation.

    Evidence Lineage tracing, conditional knockout, scRNA-seq and bisulfite sequencing in exhaustion models

    PMID:32579593 PMID:33128876

    Open questions at the time
    • Enzymes depositing Tcf7 methylation not identified
    • Causality of methylation versus consequence partially resolved
  15. 2021 High

    Confirmed a cell-intrinsic role for TCF-1 in human T cell expansion and revealed post-transcriptional control of Tcf7 by Regnase-1 governing Tpex formation.

    Evidence CRISPR-Cas9 in human primary T cells and Regnase-1 knockout with mRNA targeting in CAR-T xenografts

    PMID:33351785 PMID:33690816

    Open questions at the time
    • Therapeutic durability of Tcf7 modulation untested long-term
    • Regnase-1 target specificity single-lab
  16. 2022 High

    Established TCF-1 as an organizer of 3D genome architecture through CTCF co-occupancy and NIPBL recruitment, and clarified upstream signals (TGF-beta, IL-10R/STAT3) maintaining TCF-1+ stem-like cells.

    Evidence Hi-C, ChIP-seq for H3K27ac/NIPBL, single-cell CRISPR, and conditional knockouts of TGF-beta and Il10rb/Stat3 pathways

    PMID:34879221 PMID:35594339 PMID:35726060 PMID:35980386

    Open questions at the time
    • Direct biochemical interaction of TCF-1 with NIPBL/cohesin not shown
    • How TCF-1 selects loop-forming sites unresolved
  17. 2021 High

    Extended TCF-1's repressor role to regulatory and tissue-resident lineages, suppressing Foxp3-co-bound genes in Tregs and effector programs in colonic gamma-delta T-IELs.

    Evidence Cell-type-specific conditional knockouts with scRNA-seq in Treg and gamma-delta IEL tumor models

    PMID:34385712 PMID:37801516

    Open questions at the time
    • Mechanism of TCF-1/Foxp3 co-repression not biochemically defined
    • Lineage-specific cofactors not identified

Open questions

Synthesis pass · forward-looking unresolved questions
  • How TCF-1 mechanistically toggles between activation and repression, engages nucleosomes structurally, and physically couples to cohesin/NIPBL to build TADs remains unresolved.
  • No structural model of TCF-1 on nucleosomal DNA
  • Direct TCF-1-NIPBL/cohesin interaction unconfirmed
  • Domain logic of activator-versus-repressor switching undefined

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0003677 DNA binding 4 GO:0140110 transcription regulator activity 4 GO:0042393 histone binding 2
Localization
GO:0000228 nuclear chromosome 3 GO:0005634 nucleus 2
Pathway
R-HSA-162582 Signal Transduction 4 R-HSA-168256 Immune System 4 R-HSA-4839726 Chromatin organization 4 R-HSA-74160 Gene expression (Transcription) 4 R-HSA-1266738 Developmental Biology 3
Partners
CTCFCTNNB1HEBJUPLEF1NIPBLRUNX3UCHL5

Evidence

Reading pass · 45 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1991 TCF-1 was identified and cloned as a T lymphocyte-specific transcription factor containing a single sequence-specific HMG box that binds a heptamer motif in the CD3-epsilon enhancer; upon cotransfection into non-T cells, TCF-1 transactivated through its cognate motif, establishing it as a T cell-specific transcriptional activator. Protein purification, gel retardation assay, cotransfection/reporter assay, cDNA cloning The EMBO journal High 1989880
1991 Murine TCF-1 recognizes the same sequence motif in the CD3-epsilon enhancer as human TCF-1, and the HMG box region alone is sufficient for sequence-specific DNA binding; TCF-1 also binds specifically to a functional element in the TCR-alpha enhancer. Gel retardation assay, methylation interference, deletion analysis, Northern blot, in situ hybridization The Journal of experimental medicine High 1827138
1991 TCF-1 binds specifically to the T beta 5 element of the TCR-beta enhancer and the T delta 7 element of the TCR-delta enhancer, defining a consensus motif A/T A/T CAAA/GAG recognized by TCF-1 across multiple T cell-specific gene enhancers. Gel retardation analysis International immunology Medium 1836958
1992 The HMG boxes of TCF-1 and SRY recognize the heptamer motif predominantly through contacts in the minor groove of DNA, not the major groove, as demonstrated by methylation interference and DEPC carbethoxylation interference footprinting, and by T-to-C and A-to-inosine substitutions that change major groove but not minor groove surfaces. Methylation interference footprinting, DEPC interference footprinting, base substitution analysis The EMBO journal High 1639073
1993 TCF-1/hLEF contains a context-dependent transcriptional activation domain (approximately amino acids 80–256) that is separate from the HMG box and is preferentially active in T cells; this activation domain requires TCF-2 binding at flanking sites within the TCR-alpha enhancer for full activity, demonstrating cooperative enhancer function. GAL4 fusion transactivation assay, deletion mutagenesis, clustered amino acid substitution, cotransfection/reporter assay in T cell lines Genes & development High 8253387
1995 Human TCF-1 protein is expressed exclusively in the nucleus of T lineage cells in normal tissues, produces multiple isoforms (25–55 kDa) by alternative splicing, and is detectable in all stages of T cell malignancy tested, consistent with a T cell-specific nuclear transcription factor function. Monoclonal antibody generation, Western blot, immunohistochemistry, immunocytochemistry Blood Medium 7579399
1996 TCF-1 is encoded by an extensively alternatively spliced gene with a dual-promoter architecture; an alternative upstream promoter adds 116 amino acids to the N-terminus, producing isoforms resembling LEF-1 that can transactivate through the TCR-alpha enhancer, while shorter isoforms lack this capacity, establishing functional differences between TCF-1 isoforms. Western blot, cDNA cloning, 5' RACE, PCR, cotransfection/reporter assay Molecular and cellular biology High 8622675
1998 TCF-1 deficiency causes progressive failure of thymocyte expansion at two DN stages (CD44+CD25+ and CD44-CD25-) normally characterized by extensive proliferation; this defect is cell-intrinsic as Tcf-1-/- progenitors fail to expand in normal thymic environments, implicating TCF-1 (as a Wnt/beta-catenin effector) in driving DN thymocyte proliferation. Tcf-1 knockout mouse analysis, fetal thymic organ culture, intrathymic injection of knockout progenitors, flow cytometry Journal of immunology High 9780167
1999 TCF-1 binds to two sites in the Ly49A promoter and regulates its transcriptional activity; TCF-1 determines the size of the Ly49A NK cell subset in vivo in a dosage-dependent manner, establishing TCF-1 as a trans-acting factor for clonal NK cell receptor acquisition. Gel shift/promoter binding assay, Tcf-1 knockout and heterozygous mouse analysis, flow cytometry Immunity High 10549625
1999 In T cells, TCF-1 becomes transcriptionally active through interaction with beta-catenin, indicating the Wnt signal transduction pathway is operational in T lymphocytes; however, unlike fibroblasts, GSK-3beta inhibition alone (by lithium or dominant-negative GSK-3beta) is insufficient to activate TCF-dependent transcription in T cells, revealing a cell-type-specific difference in Wnt pathway regulation. TCF reporter assay in T cells vs. fibroblasts, dominant-negative GSK-3beta expression, lithium treatment, cotransfection International immunology Medium 10221643
2001 The beta-catenin-binding domain of TCF-1 is required for survival of immature CD4+CD8+ double-positive thymocytes; loss of TCF-1 leads to Bcl-xL downregulation and accelerated apoptosis, which is rescued by a Bcl-2 transgene, placing TCF-1/beta-catenin upstream of anti-apoptotic gene expression in thymocyte survival. TCF-1 knockout mouse analysis with catenin-binding domain mutant knock-in, Bcl-2 transgene rescue, flow cytometry, Western blot Nature immunology High 11477404
2001 Wnt1 and Wnt4 signals activate TCF-dependent transcriptional activity in thymocytes (demonstrated using TCF-LacZ reporter mice); the interaction of beta-catenin with TCF-1 is required for full thymocyte development, and retroviral expression of soluble Wnt receptor mutants blocking Wnt signaling inhibits thymocyte development in vitro. TCF-LacZ reporter mice, retroviral expression of dominant-negative Wnt receptor, in vitro thymocyte culture, flow cytometry European journal of immunology High 11265645
2005 TCF-1 ensures survival of pre-TCR+ thymocytes via its N-terminal catenin-binding domain; pre-TCR signaling significantly induces TCF-1 expression and activates a Wnt/catenin/TCF reporter transgene in vivo, while Wnt signals provide beta-catenin as coactivator, demonstrating cooperation between pre-TCR and Wnt/TCF-1 pathways for thymocyte survival. TCF-1 catenin-binding domain mutant mice, TCF reporter transgene in vivo, gamma-catenin knockout analysis, flow cytometry Blood High 15890681
2010 TCF-1 programs CD8 memory T cell fate; Tcf-1-deficient CD8 T cells lack memory precursor cells (detectable at peak of primary response) and fail to expand upon secondary challenge; this function requires the catenin-binding domain in TCF-1 and depends on beta-catenin and gamma-catenin as coactivators, establishing the Wnt/TCF-1 pathway as essential for CD8 central memory differentiation. Tcf-1 knockout mouse, LCMV infection model, adoptive transfer, catenin-binding domain mutant analysis, flow cytometry PNAS High 20457902
2011 TCF-1 represses IL-17 gene expression via epigenetic modifications during T cell development; TCF-1 deficiency leads to hyperacetylation and H3K4 trimethylation (active marks) at the IL-17 locus in thymocytes, and this epigenetic state is maintained in peripheral T cells, demonstrating TCF-1 maintains chromatin in a repressive state at the IL-17 locus. Tcf-1 knockout mouse, chromatin immunoprecipitation (ChIP) for histone marks, Rag1-/- reconstitution, flow cytometry, EAE model PLoS ONE High 21935461
2011 TCF-1 is a critical regulator of T-lineage specification; forced expression of TCF-1 in bone marrow progenitors drives T-lineage development even in the absence of T-inductive Notch1 signals, and TCF-1 upregulates T-cell essential genes including Gata3, Bcl11b, and TCR components, placing TCF-1 downstream of Notch in a T cell specification cascade. Conditional TCF-1 overexpression in bone marrow progenitors, Notch1-deficient background, flow cytometry, gene expression analysis Nature High 21814277
2012 TCF-1 directly represses LEF-1 expression in early thymocytes; Tcf7-/- mice develop T cell malignancy resembling T-ALL in which LEF-1 is aberrantly upregulated, and conditional inactivation of Lef1 greatly delayed or prevented malignancy in Tcf7-/- mice, establishing TCF-1 as a direct transcriptional repressor of LEF-1 and a tumor suppressor in T cell development. Tcf7 knockout mouse, conditional Lef1 knockout rescue, ChIP (direct repression), flow cytometry, histopathology Immunity High 23103132
2014 TCF-1 and LEF-1 promote CD4+ T cell fate by directly and positively regulating the transcription factor Th-POK; additionally, TCF-1 physically interacts with Runx3 to cooperatively silence Cd4 in CD8-lineage T cells, demonstrating TCF-1 operates through distinct molecular interactions (Th-POK activation; Runx3 cooperation) to specify helper vs. cytotoxic T cell identity. Conditional knockout in DP thymocytes, Co-immunoprecipitation (TCF-1/Runx3 interaction), ChIP, flow cytometry Nature immunology High 24836425
2015 TCF-1 initiates TFH differentiation by directly binding the Bcl6 promoter to promote Bcl-6 expression and the Prdm1 5' regulatory regions to repress Blimp1 expression, placing TCF-1 as a transcriptional hub upstream of the Bcl-6/Blimp1 axis for TFH cell commitment. ChIP (direct promoter binding), Tcf7 conditional knockout, viral infection model, flow cytometry Nature immunology High 26214740
2015 LEF-1 and TCF-1 cooperatively regulate TFH differentiation by establishing responsiveness of naive CD4+ T cells to TFH signals and sustaining expression of IL-6Rα, gp130, ICOS, and Bcl6; single or double knockout shows additive defects, with combined Lef1/Tcf7 deletion severely impairing TFH differentiation and germinal center formation. Single and double conditional knockout mice, LCMV infection model, flow cytometry, gene expression analysis Nature immunology High 26214741
2015 TCF-1 is required for efficient generation of all adult ILC subsets; TCF-1-high early ILC progenitors (EILPs) are the earliest ILC-committed progenitors lacking T and B lymphocyte potential, indicating TCF-1 upregulation marks the earliest stage of ILC fate specification. TCF-1 reporter mice, conditional knockout, lineage tracing, adoptive transfer, flow cytometry Nature immunology High 26280998
2018 TCF-1 is a lineage-determining transcription factor that establishes the epigenetic identity of T cells by targeting silent chromatin and opening regulatory regions at the earliest stages of T cell development; TCF-1 expression in fibroblasts generates de novo chromatin accessibility even at regions with repressive marks, inducing T cell-restricted genes, demonstrating pioneer transcription factor activity. ATAC-seq across eight T cell developmental stages, TCF-1 loss-of-function, ectopic TCF-1 expression in fibroblasts, chromatin accessibility profiling Immunity High 29466756
2018 TCF-1 and HEB share ~7,000 DNA-binding sites genome-wide in CD4+CD8+ thymocytes; TCF-1 displaces nucleosomes to allow chromatin accessibility and prevents Notch-mediated proteasomal degradation of HEB, thereby enabling TCF-1/HEB cooperation in establishing the epigenetic and transcription profiles of DP thymocytes. ChIP-seq, ATAC-seq, Co-IP, Notch pathway manipulation, TCF-1 and HEB conditional knockouts Nature immunology High 30420627
2019 TCF-1 mediates an early fate bifurcation between terminal KLRG1hi effectors and KLRG1lo exhausted T cell precursors during chronic infection; it promotes Eomes expression (mediating T-bet-to-Eomes transition) and drives c-Myb expression controlling Bcl-2 and survival, while repressing terminal effector development; PD-1 stabilizes the TCF-1+ precursor pool. scRNA-seq, lineage tracing, Tcf7 conditional knockout, LCMV chronic infection model, flow cytometry Immunity High 31606264
2019 TCF-1 limits Tc17 cell differentiation in DP thymocytes through sequential suppression of the transcription factors MAF and RORγt, in parallel with TCF-1-driven modulation of chromatin state; ablation of TCF-1 enhances Tc17 development. Conditional TCF-1 knockout, ATAC-seq, flow cytometry, gene expression analysis The Journal of experimental medicine High 31142588
2019 TCF-1 enforces ILC lineage commitment by using a pre-existing regulatory landscape established in upstream lymphoid precursors to bind chromatin in EILPs, and is required for generation of committed EILPs but not specified EILPs, demonstrating a stage-specific epigenetic mechanism for TCF-1 in ILC commitment. scRNA-seq, conditional TCF-1 knockout, ATAC-seq, adoptive transfer Nature immunology High 31358996
2019 TCF-1 has intrinsic histone deacetylase (HDAC) activity that is essential for its functions in T cell and ILC lineage commitment and maintenance, functioning independently of Wnt/beta-catenin in certain contexts. Review citing experimental evidence from primary studies Trends in immunology Low 31734149
2020 Tcf7 (Tcf1) counteracts cytolytic differentiation in effector-phase CD8 T cells and sustains expression of conserved adult stem-cell genes critical for stemness; Tcf7hi effector cells lacking cytolytic differentiation markers quantitatively yield central memory CD8 T cells, as demonstrated by lineage tracing. Lineage tracing, Tcf7 conditional knockout, scRNA-seq, flow cytometry, LCMV acute infection model Immunity High 33128876
2020 Tcf7 promoter DNA methylation contributes to TCF-1 downregulation in exhausted CD8 T cells; repeat antigenic stimulation induces Tcf7 promoter methylation concurrent with exhaustion, demonstrated in a novel in vitro exhaustion model validated against in vivo LCMV-exhausted cells. In vitro repeated peptide stimulation exhaustion model, bisulfite sequencing/DNA methylation analysis, transcriptomic comparison with LCMV-exhausted cells PLoS pathogens Medium 32579593
2021 TCF-1 directly regulates CD8 T cell expansion capacity; CRISPR-Cas9 deletion of TCF-1 in human primary T cells directly reduces secondary expansion capacity, establishing a cell-intrinsic role for TCF-1 in regulating stem-like memory properties independent of viral load. CRISPR-Cas9 gene editing in human primary T cells, expansion assays, flow cytometry JCI insight High 33351785
2021 Regnase-1 directly targets Tcf7 mRNA; Regnase-1 deficiency augments TCF-1 expression in CAR-T cells leading to increased formation of TCF-1+ precursor exhausted T cells (Tpex) with enhanced tumor clearance and long-term persistence. Regnase-1 knockout, RNA binding/mRNA stability assay, phenotypic profiling, xenograft model Blood Medium 33690816
2021 TCF-1 primarily suppresses transcription of genes co-bound by Foxp3 in Treg cells; TCF-1 deficiency in Tregs promotes alternative signaling pathways, TH17-like characteristics, and gut-homing properties, while strongly suppressing T cell cytotoxicity but impairing control of CD4+ T cell polarization and inflammation. Treg-specific TCF-1 conditional knockout, scRNA-seq, flow cytometry, tumor model Nature immunology High 34385712
2022 TCF-1 promotes chromatin interactions across topologically associating domain (TAD) boundaries in T cell progenitors; co-occupancy of TCF-1 and CTCF alters TAD structure, and TCF-1-dependent long-range interactions are linked to deposition of H3K27ac and recruitment of the cohesin-loading factor NIPBL at active enhancers. Hi-C/3D genome profiling, ATAC-seq, ChIP-seq for H3K27ac and NIPBL, TCF-1 gain- and loss-of-function Nature immunology High 35726060
2022 TGF-β signaling is not required for generation of stem-like PD-1+TCF-1+ CD8 T cells during chronic LCMV infection but is critical for maintaining their stem-like state and quiescence; TGF-β regulates the unique transcriptional program of the stem-like subset including expression of inhibitory receptors specifically expressed on these cells. TGF-β signaling conditional knockout, LCMV chronic infection, scRNA-seq, flow cytometry The Journal of experimental medicine High 35980386
2022 TCF-1-mediated early T cell development proceeds through a kinetic competition between TCF-1 (Tcf7) and Gata3 as T cell-promoting factors versus Spi1 (PU.1) and Bcl11a as progenitor factors, with an unexpected guidance role for Erg; defined by single-cell CRISPR disruption at distinct early stages of T cell development. Single-cell CRISPR disruption, scRNA-seq with batch indexing, synchronized in vitro differentiation Science immunology Medium 35594339
2017 Ubiquitin C-terminal hydrolase 37 (Uch37), a deubiquitinase, interacts with Tcf7 and promotes its binding to target gene promoters; the deubiquitinating activity of Uch37 is not required for Tcf7 protein stability but is required for chromatin occupancy of Tcf7 at target genes in both Xenopus embryos and human liver cancer cells. Co-immunoprecipitation, biochemical assays for deubiquitinase activity, chromatin occupancy assay (ChIP), Xenopus in vivo analysis, human cell experiments Scientific reports Medium 28198400
2010 Runx2 directly activates the Tcf7 promoter in chondrocytes; Runx2 induces Tcf7 and Lef1 expression in Runx2-/- chondrocytes, and dominant-negative Tcf7 transgenic mice show retarded chondrocyte maturation and reduced proliferation, placing Tcf7 downstream of Runx2 in skeletal development. Microarray, reporter assay, Runx2-/- chondrocyte reconstitution, dominant-negative Tcf7 transgenic mice, BrdU labeling, in situ hybridization Journal of bone and mineral metabolism Medium 20890621
2009 In normal colon cells, a dominant-negative TCF-1 isoform (dnTCF-1) is equally distributed between nuclear and cytoplasmic compartments; in colon cancer cells, TCF-1 is predominantly cytoplasmic due to active nuclear export directed by an autocrine Wnt ligand requiring Ca2+/calmodulin-dependent kinase II (CaMKII) activity for secretion, demonstrating Wnt/CaMKII-regulated nuclear export of TCF-1. Subcellular fractionation, nuclear export assay, pharmacological inhibition of CaMKII, Wnt ligand conditioned medium experiments Oncogene Medium 19749792
2012 TCF7 regulates a self-renewal/differentiation switch in multipotential hematopoietic progenitor cells independent of autocrine Wnt signaling; ChIP-seq identified TCF7 target genes, and TCF7 binds to RUNX1 promoter regions and is necessary for production of short RUNX1 isoforms but not long isoforms, suggesting coordinated regulation between TCF7 and short RUNX1. RNA-seq, ChIP-seq, TCF7 knockdown, EML hematopoietic cell model PLoS genetics Medium 22412390
2020 A shared 1 kb regulatory element controls initiation of Tcf7 expression in both T cells and ILCs; within this element, a Notch binding site is important for Tcf7 initiation in T cells but not ILCs, demonstrating lineage-specific transcriptional control of Tcf7 through a common cis-regulatory element. Regulatory element reporter assay, Notch binding site mutation, conditional reporter mice Frontiers in immunology Medium 32265924
2010 IL-4/STAT6 signaling downregulates TCF-1 expression in human naive CD4+ T cells specifically targeting the shorter dominant-negative TCF-1 isoforms; STAT6 binds TCF-1 gene regulatory regions as demonstrated by EMSA and ChIP, providing a feedback mechanism linking IL-4 signaling to TCF-1 isoform-specific suppression. EMSA, ChIP, STAT6 knockdown, qRT-PCR in primary human T cells The Journal of biological chemistry Medium 20980261
2015 TCF-1-mediated Wnt signaling directly activates alpha-defensin HD-5 and HD-6 transcription in intestinal Paneth cells through cooperation with beta-catenin; reporter gene assays, in vitro promoter binding (EMSA), and Tcf-1 knockout mice demonstrate TCF-1 binding to three distinct TCF binding sites in the HD-5 and HD-6 promoters. Reporter gene assay, EMSA, Tcf-1 knockout mouse, qRT-PCR American journal of physiology - Gastrointestinal and liver physiology Medium 24994854
2015 AF1q specifically binds to TCF7 (by Co-IP) and functions as a transcriptional co-factor that activates CD44 and multiple downstream TCF7/LEF1 target genes, promoting breast cancer cell proliferation, migration, and metastasis. Co-immunoprecipitation, reporter assay, knockdown/overexpression, xenograft model Oncotarget Medium 26079538
2023 Targeted deletion of TCF-1 in gamma-delta T-IELs in the colon induces a distinct effector profile and reduces colon tumor formation in mice, establishing TCF-1 as a transcriptional suppressor of effector/cytotoxic function specifically in colonic intraepithelial gamma-delta T cells. Gamma-delta T cell-specific conditional TCF-1 knockout, colon tumor model, flow cytometry, scRNA-seq Science immunology High 37801516
2022 IL-10R signaling through STAT3 maintains the PD-1int TCF-1+ CD8 T cell subset; loss of Il10rb or Stat3 decreases PD-1int TCF-1+ CD8 T cell frequencies and mechanistically alters chromatin accessibility, disrupting cooperativity between NFAT and AP-1 transcription factors and promoting an NFAT-dependent exhaustion program. Il10rb/Stat3 conditional knockout, scRNA-seq, ATAC-seq, flow cytometry, CLL mouse model Immunity Medium 34879221

Source papers

Stage 0 corpus · 100 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2019 TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision. Immunity 572 31606264
1991 Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box. The EMBO journal 513 1989880
2011 A critical role for TCF-1 in T-lineage specification and differentiation. Nature 338 21814277
2010 Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory. Proceedings of the National Academy of Sciences of the United States of America 305 20457902
2015 LEF-1 and TCF-1 orchestrate T(FH) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6. Nature immunology 289 26214741
2015 TCF-1 upregulation identifies early innate lymphoid progenitors in the bone marrow. Nature immunology 242 26280998
2021 Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes. Immunity 232 34534439
1993 Differential expression of the HMG box factors TCF-1 and LEF-1 during murine embryogenesis. Development (Cambridge, England) 228 8223271
2015 The transcription factor TCF-1 initiates the differentiation of T(FH) cells during acute viral infection. Nature immunology 201 26214740
2001 The beta-catenin--TCF-1 pathway ensures CD4(+)CD8(+) thymocyte survival. Nature immunology 201 11477404
1992 Sequence-specific interaction of the HMG box proteins TCF-1 and SRY occurs within the minor groove of a Watson-Crick double helix. The EMBO journal 199 1639073
1998 Critical involvement of Tcf-1 in expansion of thymocytes. Journal of immunology (Baltimore, Md. : 1950) 187 9780167
1996 Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties. Molecular and cellular biology 176 8622675
2018 Lineage-Determining Transcription Factor TCF-1 Initiates the Epigenetic Identity of T Cells. Immunity 172 29466756
2020 Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation. Immunity 162 33128876
2021 Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p/TCF7 axis. Molecular cancer 159 34172072
1993 The hLEF/TCF-1 alpha HMG protein contains a context-dependent transcriptional activation domain that induces the TCR alpha enhancer in T cells. Genes & development 157 8253387
2001 Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription. European journal of immunology 154 11265645
2012 The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy. Immunity 152 23103132
2014 TCF-1 and LEF-1 act upstream of Th-POK to promote the CD4(+) T cell fate and interact with Runx3 to silence Cd4 in CD8(+) T cells. Nature immunology 142 24836425
2008 Insertional mutagenesis by the Tol2 transposon-mediated enhancer trap approach generated mutations in two developmental genes: tcf7 and synembryn-like. Development (Cambridge, England) 139 18065431
1991 Cloning of murine TCF-1, a T cell-specific transcription factor interacting with functional motifs in the CD3-epsilon and T cell receptor alpha enhancers. The Journal of experimental medicine 137 1827138
1990 Purification of TCF-1 alpha, a T-cell-specific transcription factor that activates the T-cell receptor C alpha gene enhancer in a context-dependent manner. The New biologist 117 2083253
2013 TCF-1 controls ILC2 and NKp46+RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation. Journal of immunology (Baltimore, Md. : 1950) 115 24038093
1996 Involvement of transcription factors TCF-1 and GATA-3 in the initiation of the earliest step of T cell development in the thymus. The Journal of experimental medicine 112 9064330
2021 Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity. Immunity 105 34879221
2019 The transcription factor TCF-1 enforces commitment to the innate lymphoid cell lineage. Nature immunology 101 31358996
2004 IL-7 receptor signals inhibit expression of transcription factors TCF-1, LEF-1, and RORgammat: impact on thymocyte development. The Journal of experimental medicine 97 15365098
2022 In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue. The Journal of experimental medicine 95 35472220
2021 Role of TCF-1 in differentiation, exhaustion, and memory of CD8+ T cells: A review. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 93 33913198
2012 Tcf7 is an important regulator of the switch of self-renewal and differentiation in a multipotential hematopoietic cell line. PLoS genetics 86 22412390
2019 Control of Lymphocyte Fate, Infection, and Tumor Immunity by TCF-1. Trends in immunology 84 31734149
2015 MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer. Oncotarget 83 25436980
2021 TCF-1 regulates HIV-specific CD8+ T cell expansion capacity. JCI insight 79 33351785
2020 HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cells. Nature immunology 78 32066947
2022 BCL6-dependent TCF-1+ progenitor cells maintain effector and helper CD4+ T cell responses to persistent antigen. Immunity 76 35637103
2021 Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR-T-cell responses against ALL. Blood 76 33690816
2022 TGF-β regulates the stem-like state of PD-1+ TCF-1+ virus-specific CD8 T cells during chronic infection. The Journal of experimental medicine 72 35980386
2015 Elevated Hepatic miR-22-3p Expression Impairs Gluconeogenesis by Silencing the Wnt-Responsive Transcription Factor Tcf7. Diabetes 70 26193896
2012 β-catenin/TCF-1 pathway in T cell development and differentiation. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 70 22535304
2022 TCF-1: a maverick in T cell development and function. Nature immunology 69 35487986
2021 TCF-1 controls Treg cell functions that regulate inflammation, CD8+ T cell cytotoxicity and severity of colon cancer. Nature immunology 68 34385712
2018 Human Lymph Nodes Maintain TCF-1hi Memory T Cells with High Functional Potential and Clonal Diversity throughout Life. Journal of immunology (Baltimore, Md. : 1950) 68 30111633
1999 Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1. Immunity 68 10549625
1999 Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells. International immunology 66 10221643
2020 Rapid in vitro generation of bona fide exhausted CD8+ T cells is accompanied by Tcf7 promotor methylation. PLoS pathogens 63 32579593
2014 Multiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathway. PloS one 63 24551047
2015 Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3. Oncotarget 60 25869100
2023 STING signaling promotes NK cell antitumor immunity and maintains a reservoir of TCF-1+ NK cells. Cell reports 59 37708030
2023 Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1+ PD-1+ CD8 T cells. Science immunology 57 37624910
2022 TCF-1 promotes chromatin interactions across topologically associating domains in T cell progenitors. Nature immunology 56 35726060
2018 TCF-1 and HEB cooperate to establish the epigenetic and transcription profiles of CD4+CD8+ thymocytes. Nature immunology 56 30420627
2003 Redundant functions of TCF-1 and LEF-1 during T and NK cell development, but unique role of TCF-1 for Ly49 NK cell receptor acquisition. European journal of immunology 56 12731066
2005 Cooperating pre-T-cell receptor and TCF-1-dependent signals ensure thymocyte survival. Blood 54 15890681
2016 Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 Nexus. Cell reports 49 27806296
1995 The human TCF-1 gene encodes a nuclear DNA-binding protein uniquely expressed in normal and neoplastic T-lineage lymphocytes. Blood 48 7579399
2019 TCF-1 limits the formation of Tc17 cells via repression of the MAF-RORγt axis. The Journal of experimental medicine 47 31142588
2003 Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas. The American journal of pathology 45 12707037
1991 TCF-1, a T cell-specific transcription factor of the HMG box family, interacts with sequence motifs in the TCR beta and TCR delta enhancers. International immunology 45 1836958
2011 Critical role of TCF-1 in repression of the IL-17 gene. PloS one 44 21935461
2003 Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone. Biochemical and biophysical research communications 43 12951064
2023 The alarmin interleukin-33 promotes the expansion and preserves the stemness of Tcf-1+ CD8+ T cells in chronic viral infection. Immunity 42 36809763
2022 Single-cell deletion analyses show control of pro-T cell developmental speed and pathways by Tcf7, Spi1, Gata3, Bcl11a, Erg, and Bcl11b. Science immunology 42 35594339
2022 Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathway. Oncogene 40 35428876
2014 TCF-1-mediated Wnt signaling regulates Paneth cell innate immune defense effectors HD-5 and -6: implications for Crohn's disease. American journal of physiology. Gastrointestinal and liver physiology 40 24994854
2009 A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer. Oncogene 40 19749792
2016 Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 38 27683056
2007 The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes. BMC medical genetics 38 18045485
2015 Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation. Journal of neuroinflammation 37 26714756
1992 Identification of a core motif that is recognized by three members of the HMG class of transcriptional regulators: IRE-ABP, SRY, and TCF-1 alpha. Journal of cellular biochemistry 37 1618927
2015 AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis. Oncotarget 36 26079538
2003 A polymorphism in the TCF7 gene, C883A, is associated with type 1 diabetes. Diabetes 36 12765974
2022 Pancreatic stellate cells exploit Wnt/β-catenin/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth. Cancer letters 35 36565920
2020 A Shared Regulatory Element Controls the Initiation of Tcf7 Expression During Early T Cell and Innate Lymphoid Cell Developments. Frontiers in immunology 33 32265924
2023 Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine. Cancer letters 32 38101610
2021 Saikosaponin-d Alleviates Renal Inflammation and Cell Apoptosis in a Mouse Model of Sepsis via TCF7/FOSL1/Matrix Metalloproteinase 9 Inhibition. Molecular and cellular biology 30 34309413
2019 Opposing roles of TCF7/LEF1 and TCF7L2 in cyclin D2 and Bmp4 expression and cardiomyocyte cell cycle control during late heart development. Laboratory investigation; a journal of technical methods and pathology 30 30778164
2021 TCF-1 maintains CD8+ T cell stemness in tumor microenvironment. Journal of leukocyte biology 29 34047386
2018 Long non-coding RNA TCF7 contributes to the growth and migration of airway smooth muscle cells in asthma through targeting TIMMDC1/Akt axis. Biochemical and biophysical research communications 29 30528236
2018 The Disruption of the β-Catenin/TCF-1/STAT3 Signaling Axis by 4-Acetylantroquinonol B Inhibits the Tumorigenesis and Cancer Stem-Cell-Like Properties of Glioblastoma Cells, In Vitro and In Vivo. Cancers 29 30563094
2016 Long noncoding RNA TCF7 promotes invasiveness and self-renewal of human non-small cell lung cancer cells. Human cell 29 27766570
2009 Evidence for association of the TCF7 locus with type I diabetes. Genes and immunity 29 19956102
2005 lin-17/Frizzled and lin-18 regulate POP-1/TCF-1 localization and cell type specification during C. elegans vulval development. Developmental biology 29 15649465
2023 BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8+ T cells. Leukemia 28 36681742
2010 Inhibition of suppressive T cell factor 1 (TCF-1) isoforms in naive CD4+ T cells is mediated by IL-4/STAT6 signaling. The Journal of biological chemistry 28 20980261
2005 Expression pattern of zebrafish tcf7 suggests unexplored domains of Wnt/beta-catenin activity. Developmental dynamics : an official publication of the American Association of Anatomists 28 15765502
1997 Ectopic activation of lymphoid high mobility group-box transcription factor TCF-1 and overexpression in colorectal cancer cells. International journal of cancer 28 9259402
2018 Down-regulation of lncTCF7 inhibits cell migration and invasion in colorectal cancer via inhibiting TCF7 expression. Human cell 27 30225781
2014 Wnt signaling transcription factors TCF-1 and LEF-1 are upregulated in malignant astrocytic brain tumors. Histology and histopathology 27 24858819
2012 Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions. The Journal of clinical investigation 27 22466651
2010 Regulation of Tcf7 by Runx2 in chondrocyte maturation and proliferation. Journal of bone and mineral metabolism 27 20890621
1992 A common ancestor of the mammalian transcription factors TCF-1 and TCF-1 alpha/LEF-1 expressed in chicken T cells. European journal of immunology 27 1577072
2017 TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer. Prostate cancer and prostatic diseases 26 28220803
2023 TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma. Science immunology 25 37801516
2020 Exploring the stage-specific roles of Tcf-1 in T cell development and malignancy at single-cell resolution. Cellular & molecular immunology 25 32868912
2017 Ubiquitin C-terminal hydrolase37 regulates Tcf7 DNA binding for the activation of Wnt signalling. Scientific reports 24 28198400
2017 Andrographolide Induces Cell Cycle Arrest and Apoptosis of Chondrosarcoma by Targeting TCF-1/SOX9 Axis. Journal of cellular biochemistry 24 28485543
2003 Tcf-1 expression during Xenopus development. Gene expression patterns : GEP 23 12711535
2021 Soybean-derived gma-miR159a alleviates colon tumorigenesis by suppressing TCF7/MYC in mice. The Journal of nutritional biochemistry 22 33705946
2018 T Cell Factor 7 (TCF7)/TCF1 Feedback Controls Osteocalcin Signaling in Brown Adipocytes Independent of the Wnt/β-Catenin Pathway. Molecular and cellular biology 22 29358218

Missed literature

Know a paper Affinage missed for TCF7? Flag it for the maintainers and the community.

No submissions yet.